Caxton Corp as of June 30, 2024
Portfolio Holdings for Caxton Corp
Caxton Corp holds 12 positions in its portfolio as reported in the June 2024 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Xeris Pharmaceuticals (XERS) | 58.3 | $12M | 5.1M | 2.25 | |
| Rezolute Com New (RZLT) | 28.7 | $5.7M | 1.3M | 4.30 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 5.2 | $1.0M | 1.9k | 544.10 | |
| Berkshire Hathaway Inc Del Cl B New (BRK.B) | 2.1 | $417k | 1.0k | 406.90 | |
| Lexeo Therapeutics (LXEO) | 1.5 | $286k | 18k | 16.04 | |
| Mind Medicine Com New (MNMD) | 1.1 | $219k | 30k | 7.21 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.9 | $184k | 14k | 13.22 | |
| Kyverna Therapeutics (KYTX) | 0.9 | $172k | 23k | 7.50 | |
| Molecular Templates Com New (MTEM) | 0.8 | $157k | 137k | 1.15 | |
| Compass Therapeutics (CMPX) | 0.2 | $44k | 44k | 1.00 | |
| Context Therapeutics (CNTX) | 0.2 | $37k | 18k | 2.01 | |
| Adicet Bio (ACET) | 0.1 | $21k | 18k | 1.21 |
